drugset / Trial / NCT04719065
A Study of Mitoxantrone Hydrochloride Liposome Injection in the Treatment of Advanced Solid Tumor
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a multicenter, randomized, open-label, phase Ib study to evaluate the safety, efficacy and pharmacokinetic characteristics of Mitoxantrone Hydrochloride Liposome in subjects with advanced solid tumor.
Timeline
- Start
- 2021-01-13
- Primary completion
- 2022-04-13
- Completion
- 2024-04-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mitoxantrone | Small molecule | 20 mg/m2 | Intravenous |